An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Senseonics to Participate in Upcoming November Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Senseonics Holdings, Inc. (AMEX: SENS) has announced participation in two upcoming investor conferences. Management will engage in a virtual fireside chat on November 16, 2021, at 8:40am ET during the Stifel 2021 Virtual Healthcare Conference. Additionally, a presentation will be available on November 18, 2021, at 3:00am ET at the Jefferies London Healthcare Conference. Interested parties can access live and on-demand webcasts on the Company’s website. Senseonics focuses on long-term glucose monitoring systems for diabetes management.
Positive
None.
Negative
None.
GERMANTOWN, Md.--(BUSINESS WIRE)--
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in two upcoming investor conferences.
Stifel 2021 Virtual Healthcare Conference Management will participate in a virtual fireside chat on Tuesday, November 16, 2021 at 8:40am ET.
Jefferies London Healthcare Conference A presentation from management will be made available on Thursday, November 18, 2021 at 3:00am ET.
Interested parties may access these live and on-demand webcasts on the “Investors” section of the Company’s website at www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' CGM systems, Eversense® and Eversense® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.
Senseonics Investor Relations Contact:
Lynn Lewis or Philip Taylor Investor Relations
415-937-5406
Investors@senseonics.com
Source: Senseonics Holdings, Inc.
FAQ
What are the dates for Senseonics' participation in the investor conferences?
Senseonics will participate in the Stifel 2021 Virtual Healthcare Conference on November 16, 2021, and the Jefferies London Healthcare Conference on November 18, 2021.
What time is Senseonics' virtual fireside chat?
The virtual fireside chat at the Stifel 2021 Virtual Healthcare Conference will be held at 8:40am ET on November 16, 2021.
Where can I watch Senseonics' presentations from the investor conferences?
You can access the live and on-demand webcasts of Senseonics' presentations on the 'Investors' section of their website.
What is the focus of Senseonics Holdings, Inc.?
Senseonics is focused on developing long-term, implantable continuous glucose monitoring systems for people with diabetes.
What products does Senseonics offer?
Senseonics offers glucose monitoring products, including the Eversense® and Eversense® XL continuous glucose monitoring systems.
